4.7 Article

Loss of hepatic DEPTOR alters the metabolic transition to fasting

Journal

MOLECULAR METABOLISM
Volume 6, Issue 5, Pages 447-458

Publisher

ELSEVIER
DOI: 10.1016/j.molmet.2017.02.005

Keywords

DEPTOR; mTOR; Liver; Glucose; Fasting

Funding

  1. Canadian Institutes of Health Research (CIHR) [MOP123387]
  2. Natural Sciences and Engineering Research Council of Canada (NSERC) [418158-2012]
  3. Les Fonds de recherche du Quebec - Sante (FRQS) [24726]
  4. Le Reseau de recherche en sante cardiometabolique, diabete et obesite (CMDO)
  5. Le Reseau de bio-imagerie du Quebec (RBIQ)
  6. Diabete Quebec
  7. La Fondation de l'Institut universitaire de cardiologie et de pneumologie de Quebec - Universite Laval (IUCPQ-UL)
  8. NIH [R01 CA103866, AI47389]
  9. CIHR Training Program in Obesity/Healthy Body Weight
  10. Canadian Diabetes Association

Ask authors/readers for more resources

Objective: The mechanistic target of rapamycin (mTOR) is a serine/threonine kinase that functions into distinct protein complexes (mTORC1 and mTORC2) that regulates growth and metabolism. DEP-domain containing mTOR-interacting protein (DEPTOR) is part of these complexes and is known to reduce their activity. Whether DEPTOR loss affects metabolism and organismal growth in vivo has never been tested. Methods: We have generated a conditional transgenic mouse allowing the tissue-specific deletion of DEPTOR. This model was crossed with CMV-cre mice or Albumin-cre mice to generate either whole-body or liver-specific DEPTOR knockout (KO) mice. Results: Whole-body DEPTOR KO mice are viable, fertile, normal in size, and do not display any gross physical and metabolic abnormalities. To circumvent possible compensatory mechanisms linked to the early and systemic loss of DEPTOR, we have deleted DEPTOR specifically in the liver, a tissue in which DEPTOR protein is expressed and affected in response to mTOR activation. Liver-specific DEPTOR null mice showed a reduction in circulating glucose upon fasting versus control mice. This effect was not associated with change in hepatic gluconeogenesis potential but was linked to a sustained reduction in circulating glucose during insulin tolerance tests. In addition to the reduction in glycemia, liver-specific DEPTOR KO mice had reduced hepatic glycogen content when fasted. We showed that loss of DEPTOR cell-autonomously increased oxidative metabolism in hepatocytes, an effect associated with increased cytochrome c expression but independent of changes in mitochondrial content or in the expression of genes controlling oxidative metabolism. We found that liver-specific DEPTOR KO mice showed sustained mTORC1 activation upon fasting, and that acute treatment with rapamycin was sufficient to normalize glycemia in these mice. Conclusion: We propose a model in which hepatic DEPTOR accelerates the inhibition of mTORC1 during the transition to fasting to adjust metabolism to the nutritional status. (C) 2017 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available